Summary: Annual commercialization event offers attendees access to emerging therapeutic and diagnostic SickKids technologies with high potential for market disruption and clinical impact.
The SickKids Innovation Showcase is returning for its second year, bringing together the latest in cutting-edge innovation at The Hospital for Sick Children (SickKids) with investors who can help advance ideas with the potential to improve health outcomes for patients. Hosted by the Industry Partnerships & Commercialization office at SickKids, the SickKids Innovation Showcase celebrates some of the most advanced health and life sciences ideas from the labs and clinics of SickKids innovators.
Attendees, primarily made up early-stage investors, venture capitalists, as well as pharmaceutical and biotechnology firms, get unparalleled access to emerging therapeutic and diagnostic technologies with high potential for market disruption and clinical impact.
Last year, over 200 people tuned into the virtual event to learn about the most advanced life science opportunities from SickKids, as well as to hear perspectives from top industry experts. This year, the event features seven of the top opportunities ripe for partnerships.
The virtual Innovation Showcase will be held on Tuesday, May 17. The Innovation Showcase includes pitch presentations from biopharmaceutical and medical technology research leads, followed by question-and-answer sessions and networking opportunities to meet SickKids innovators. Innovators will also have the chance to secure $10,000 in funding for their research, based on the audience’s vote for best presentation of the day.